NAKAYAMA; Tomoharu ¹ , FOONG; Anthony FW ² 

¹ Nakayama Clinic, 8-251-1, Kita-Itami, Itami City, Hyogo Prefecture 664-0831 JAPAN; (drnakayama888@nike.eonet.ne.jp)

² Imex Japan Co. Ltd. 3F, Imex Japan Bldg, 22 Shimomidori-cho, Shichiku, Kita-Ku, Kyoto 603-8425 JAPAN

A female patient, who complained of weight loss, suffered from pain with occasional numbness and tingling sensations in joints/muscles of her upper/lower extremities, and her abdominal regions, and suffered from general weakness with fatigue on a daily basis. Clinic visits revealed that she had Churg-Strauss syndrome1* or eosinophilic granulomatosis with polyangiitis (EGPA)*. Early clinical data showed high C-reactive protein (CRP: 5.1mg/dL) levels and eosinophil counts (9.2%), which improved to within normal ranges (CRP: <0.2 mg/dL; eosinophil counts: 3-5%) with 5-yr steroid treatment (prednisolone: 35 mg daily). However, EGPA-related signs and symptoms, AMY (amylase), and other blood and metabolic indexes registered unfavorable readings despite persistent steroid treatment. Her physical and biochemical conditions improved in a time-dependent fashion after combining steroid administration with complementary intake of functional food 3eMulti, which contained natural ingredients (such as docosahexaenoic acid, pecah beling leaf, pandan leaf, mangosteen peel extracts, nattokinase, lycopene, and beehive propolis) with multivariant purposes such as potent antioxidation, favorable blood vascular and cell-function properties. After 9-months of daily intake of the aforementioned functional food in addition to continuous steroid treatment, she recovered completely from the physical and biochemical deficits. To date, she has been enjoying good quality of life (QoL), with above-mentioned combination treatment continuing without any adverse effects. When medications alone are insufficient to treat an idiopathological disease, a combination of medication and functional food intake (particularly with effect-complementary ingredients) may improve the patient’s condition so they may be able to accommodate or normalize the pathological condition. This may lead to a more wholesome, in terms of QoL, living conditions for patients suffering from intractable disease.